Compounds and methods for conjugation of biomolecules

US11067580B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11067580-B2
Application numberUS-202016838004-A
CountryUS
Kind codeB2
Filing dateApr 1, 2020
Priority dateMar 4, 2011
Publication dateJul 20, 2021
Grant dateJul 20, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Low-copper click chemistry, 1.3-dipolar cycloadditions, and Staudinger ligations for modifying biomolecules is provided. Compositions, methods, and kits relating to low-copper click chemistry, 1.3-dipolar cycloadditions, and Staudinger ligations are also provided.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of the formula: wherein: A is a carbon; R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are hydrogen; X is selected from a reporter molecule, a carrier molecule, a solid support, and a reactive group, that are optionally bound to one or more additional fluorophores, wherein: the reporter molecule comprises a chromophore, a fluorophore, a fluorescent protein, a phosphorescent dye, a tandem dye, a particle, a hapten, an enzyme, or a radioisotope; the carrier molecule is an amino acid a peptide a protein, an antibody, an antibody fragment, an antigen, a polysaccharide, a nucleoside, a nucleotide, an oligonucleotide, a nucleic acid, a hapten, a psoralen, a hormone, a lipid, a lipid assembly, a tyramide, a synthetic polymer, a polymeric microparticle, a biological cell, a cellular compartment, an ion chelating moiety, an enzymatic substrate or a virus; the solid support is an aerogel, a hydrogel, a resin, a silica gel, a bead, a biochip, a microfluidic chip, a silicon chip, a multi-well plate, a membrane, a polymeric membrane, a particle, a derivatized plastic film, a glass bead, cotton, a plastic bead, alumina gel, polysaccharide, poly(acrylate), polystyrene, poly(acrylamide), polyol, agarose, agar, cellulose, dextran, starch, heparin, glycogen, amylopectin, mannan, inulin, nitrocellulose, diazocellulose, polyvinylchloride, polypropylene, polyethylene, nylon, latex bead, a conducting metal, a nonconducting metal, glass, magnetic bead, paramagnetic bead, superparamagnetic bead, or a magnetic support; the reactive group is a carboxylic acid, an activated ester of carboxylic acid, an amine, a hydrazine, a haloacetamide, an alkyl halide, an isothiocynate or a maleimide group; and L is —NH—C(O)—(CH 2 ) n —NH—, wherein n is 1 to 12; Z is a single covalent bond; and G is an azide. 2. The compound of claim 1 , wherein the fluorophore is a xanthene, coumarin, cyanine, pyrene, oxazine, borapolyazaindacene, or carbopyranine. 3. The compound of claim 1 , wherein the enzyme is horseradish peroxidase, alkaline phosphatase, beta-galactosidase, or beta-lactamase. 4. A method of modifying a biomolecule comprising the step of reacting in a solution a biomolecule comprising an azide reactive moiety with a compound of claim 1 to provide a modified biomolecule. 5. The method of claim 4 , wherein the biomolecule is a nucleic acid, oligonucleotide, protein, peptide, carbohydrate, polysaccharide, glycoprotein, lipid, hormone, drug, or prodrug. 6. The method of claim 4 , wherein the solution further comprises copper ions. 7. The method of claim 6 , wherein the method further comprises at least one reducing agent. 8. The method of claim 6 , wherein the method further comprises a copper chelator. 9. A kit comprising a compound of claim 1 . 10. The kit of claim 9 , wherein the kit further comprises a copper ion source. 11. The kit of claim 9 , wherein the kit further comprises at least one reducing agent. 12. The kit of claim 9 , wherein the kit further comprises a copper chelator. 13. The compound of claim 1 wherein the compound is:

Assignees

Inventors

Classifications

  • C07D213/78Primary

    Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title

  • containing three or more hetero rings · CPC title

  • Nitrogen atoms · CPC title

  • Phthaleins containing amino groups {; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes} · CPC title

  • Acids; Esters · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11067580B2 cover?
Low-copper click chemistry, 1.3-dipolar cycloadditions, and Staudinger ligations for modifying biomolecules is provided. Compositions, methods, and kits relating to low-copper click chemistry, 1.3-dipolar cycloadditions, and Staudinger ligations are also provided.
Who is the assignee on this patent?
Life Technologies Corp
What technology area does this patent fall under?
Primary CPC classification C07D213/78. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).